BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29411112)

  • 1. Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 12-month randomized controlled trial.
    Górski B; Jalowski S; Górska R; Zaremba M
    Clin Oral Investig; 2018 Nov; 22(8):2819-2828. PubMed ID: 29411112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: a 4-year follow-up of a randomized controlled trial.
    Górski B; Jalowski S; Górska R; Zaremba M
    Clin Oral Investig; 2020 Mar; 24(3):1183-1196. PubMed ID: 31324986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic outcomes following treatment of intrabony defect with guided tissue regeneration in aggressive periodontitis.
    Rakmanee T; Griffiths GS; Auplish G; Darbar U; Petrie A; Olsen I; Donos N
    Clin Oral Investig; 2016 Jul; 20(6):1227-35. PubMed ID: 26452978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intrabony defects with modified perforated membranes in aggressive periodontitis: subtraction radiography outcomes, prognostic variables, and patient morbidity.
    Górski B; Jalowski S; Górska R; Zaremba M
    Clin Oral Investig; 2019 Jul; 23(7):3005-3020. PubMed ID: 30374832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intrabony defects with anorganic bone matrix/p-15 or guided tissue regeneration in patients with aggressive periodontitis.
    Queiroz AC; Nóbrega PB; Oliveira FS; Novaes AB; Taba M; Palioto DB; Grisi MF; Souza SL
    Braz Dent J; 2013; 24(3):204-12. PubMed ID: 23969907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intrabony defects with guided tissue regeneration in aggressive periodontitis: clinical outcomes at 6 and 12 months.
    Rakmanee T; Griffiths GS; Auplish G; Darbar U; Petrie A; Olsen I; Donos N
    Clin Oral Investig; 2016 Jul; 20(6):1217-25. PubMed ID: 26411859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects.
    Gamal AY; Mailhot JM
    J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gingival crevicular fluid bone morphogenetic protein-2 release profile following the use of modified perforated membrane barriers in localized intrabony defects: a randomized clinical trial.
    Gamal AY; Aziz M; Salama MH; Iacono VJ
    J Int Acad Periodontol; 2014 Apr; 16(2):55-63. PubMed ID: 24844029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gingival crevicular fluid vascular endothelial cell growth factor and platelet-derived growth factor-BB release profile following the use of perforated barrier membranes during treatment of intrabony defects: a randomized clinical trial.
    Gamal AY; Abdel-Ghaffar KA; Iacono VJ
    J Periodontal Res; 2016 Jun; 51(3):407-16. PubMed ID: 26549803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial.
    Paolantonio M; Femminella B; Coppolino E; Sammartino G; D'Arcangelo C; Perfetti G; Perinetti G
    J Periodontol; 2010 Nov; 81(11):1587-95. PubMed ID: 20583915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
    Mengel R; Schreiber D; Flores-de-Jacoby L
    J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
    Mengel R; Soffner M; Flores-de-Jacoby L
    J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing guided tissue regeneration of periodontal defects by using a novel perforated barrier membrane.
    Gamal AY; Iacono VJ
    J Periodontol; 2013 Jul; 84(7):905-13. PubMed ID: 23003916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
    Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
    J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects.
    Chen CC; Wang HL; Smith F; Glickman GN; Shyr Y; O'Neal RB
    J Periodontol; 1995 Oct; 66(10):838-47. PubMed ID: 8537865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
    Paolantonio M
    J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
    Batista EL; Novaes AB; Simonpietri JJ; Batista FC
    J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amnion membrane as a novel barrier in the treatment of intrabony defects: a controlled clinical trial.
    Kiany F; Moloudi F
    Int J Oral Maxillofac Implants; 2015; 30(3):639-47. PubMed ID: 26009915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, radiographic, and patient-centered outcomes after use of enamel matrix proteins for the treatment of intrabony defects in patients with aggressive periodontitis: A 12-month multicenter clinical trial.
    Fileto Mazzonetto AL; Casarin RCV; Santamaria MP; Andere NMRB; Araújo CF; Videira Clima da Silva R; Purisaca JEV; Sallum EA; Sallum AW
    J Periodontol; 2021 Jul; 92(7):995-1006. PubMed ID: 33107596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.